Clinical trial Recruiting at 1 site Observational Ages 18 and up

AI tool to locate skin perforators for fibula free flap reconstruction

Official title: Validation of An Artificial Intelligence-Enabled Skin Perforator Segmentation Tool in Computer-Assisted Osteocutaneous Fibular Free Flap Harvest: A Clinical Trial

Run by The University of Hong Kong · NCT06634472 · Data updated 2026-11-12

This project will try an AI tool to automatically find the small skin blood vessels surgeons use when adults have fibula osteocutaneous free flap reconstruction.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment49 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedDecember 1, 2024
Main results expectedSeptember 30, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 3, 2026
Trial IDNCT06634472 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) who consent and are scheduled for immediate or secondary osteocutaneous fibula free flap reconstruction and can undergo preoperative CT angiography are ideal candidates.

Probably not a fit

Patients who are pregnant, medically unfit for surgery, allergic to iodinated contrast, or who have anatomical variations that prevent safe fibula harvest are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-arm, single-center observational study tests an AI-enabled vessel segmentation tool to predict skin perforator locations from preoperative CT angiography in patients undergoing fibula osteocutaneous free flap reconstruction. The AI segments vessels on CTA and outputs targeted perforator sites that are compared to intraoperative findings to count true/false positives and negatives. The primary endpoint is predictive accuracy, with secondary outcomes including sensitivity, specificity, positive predictive value, and negative predictive value. Demographics and perioperative data are collected on case report forms to support analysis of factors affecting performance.

Why it matters

Potential benefit: If accurate, the tool could improve preoperative planning and make fibula flap harvests safer, faster, and more predictable.

How similar studies have gone: Handheld Doppler and CTA have been used previously with variable concordance to actual perforator locations, and AI-based segmentation for this specific purpose is relatively novel with limited prior validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years, both genders;
2. Provided signed and dated informed consent form;
3. Indicated for immediate or secondary reconstructive surgery with osteocutaneous fibula free flap.

Exclusion Criteria:

1. Patients who are pregnant;
2. Patients who have medically compromised conditions and cannot tolerate surgery;
3. Patients who are unable to receive pre-operative computed tomography angiogram scans, such as those with iodine allergy;
4. Patients who have anatomical variation preventing the safe harvest of fibula free flap.

Where it's running

  • The University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Jane J Pu, MDS — The University of Hong Kong
  • Study coordinator: Jane J PU, MDS
  • Email: drjanepu@hku.hk
  • Phone: 852-28590534

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.